Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Tivic Health Systems, Inc. TIVC NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
18/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Tivic Health Systems, Inc. (TIVC) is a Medical - Devices company in the Healthcare sector, currently trading at $0.93. It has a SharesGrow Score of 17/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Valuation: TIVC trades at a trailing Price-to-Earnings (P/E) of -0 (S&P 500 average ~25).

Financials: revenue is $382,000, -40.3%/yr average growth. Net income is $9M (loss), growing at -2.4%/yr. Net profit margin is -2324.1% (negative). Gross margin is 8.4% (-7.9 pp trend).

Balance sheet: total debt is $6M against $17M equity (Debt-to-Equity (D/E) ratio 0.38, conservative). Current ratio is 20.13 (strong liquidity). Debt-to-assets is 20.4%. Total assets: $32M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 67/100 (Partial), Moat 0/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

TIVC SharesGrow Score Overview

31/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 0/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — TIVC

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
TIVC: -40.3%/yr revenue is, -2.4%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
67/100
Balance sheet TIVC: Debt-to-Equity (D/E) ratio 0.38 (conservative), Current ratio is 20.13 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
—
MOAT N/A
N/A
No analyst coverage available for this stock.
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
TIVC: Net profit margin is -2324.1%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.722-13.23
Volume75.06K
Avg Volume (30D)214.71K
Market Cap$1.01M
Beta (1Y)1.84
Share Statistics
Shares Outstanding$287.37K
IPO Date2021-11-11
Employees7
CEOMichael Kevin Handley
Financial Highlights & Ratios
Revenue (TTM)$382K
Gross Profit$32K
EBITDA$-7.84M
Net Income$-8.88M
Operating Income$-7.9M
Total Cash$12.65M
Total Debt$6.45M
Net Debt$-6.19M
Total Assets$31.61M
Price / Sales (P/S)2.64
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS8887053085

Price Chart

Track all markets on TradingView
TIVC
Tivic Health Systems, Inc. ↗  ·  NASDAQ Capital Marke
Healthcare • Medical - Devices
0.72 52WK RANGE 13.23

People Also View

RPID
RPID
Rapid Micro Biosystems, Inc.
$2.19
+2.82%
 VVOS
VVOS
Vivos Therapeutics, Inc.
$1.35
+10.66%
 SINT
SINT
Sintx Technologies, Inc.
$2.80
-2.44%
 TNON
TNON
Tenon Medical, Inc.
$0.81
-1.28%
 TLIS
TLIS
Talis Biomedical Corporation
$2.84
+0.00%
 HSCS
HSCS
Heart Test Laboratories, Inc.
$1.97
-0.76%
 RMED
RMED
Ra Medical Systems, Inc.
$0.59
+10.00%
 INVO
INVO
INVO Bioscience, Inc.
$0.83
-2.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message